Tianda Pharmaceuticals (HKSE:00455) Change In Receivables : HK$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Change In Receivables?

Tianda Pharmaceuticals's change in receivables for the quarter that ended in Dec. 2023 was HK$0.0 Mil. It means Tianda Pharmaceuticals's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Tianda Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2023 was HK$34.4 Mil. It means Tianda Pharmaceuticals's Accounts Receivable declined by HK$34.4 Mil from Mar. 2022 to Dec. 2023 .

Tianda Pharmaceuticals's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$70.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tianda Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 56.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tianda Pharmaceuticals's liquidation value for the six months ended in Dec. 2023 was HK$-77.2 Mil.

Tianda Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Tianda Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Change In Receivables Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-7.98

-19.62

-45.10

9.08

34.44

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Tianda Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Tianda Pharmaceuticals (HKSE:00455) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tianda Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	70.838	/	228.605	*	91
=	56.55

2. In Ben Graham's calculation of liquidation value, Tianda Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Tianda Pharmaceuticals's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	162.442	-	325.35	+	0.75 * 70.838	+	0.5 * 65.148
=	-77.2

Tianda Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines